Recent

% | $
Quotes you view appear here for quick access.

Osiris Therapeutics, Inc. Message Board

  • rdiggerg rdiggerg Jun 18, 2013 2:00 PM Flag

    more about INFUSE

    Medtronics annual sales of INFUSE in 2011 was $900,000,000. Latest fiscal year down to $500,000,000. Nearly 80% of use is off label. "...overall failed to find big benefit AND found might be harmful". So there is 400 million dollars per year of product sales, not even counting the other 500 million that should vanish from Medtronics. Let's go Osiris, grab a hefty chunk of this business.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • So, what do orthopedic surgeons or a neurosurgeons do now? Infuse was designed to help bones heal after spinal surgery, but it has recently been found that it works no better than a graft and carries side effects including an increased risk of cancer. Will the spine doctors look for another drug or biosurgery product to fuse and hasten the recovery time? Is there any competition to Ovation? Will the two hundred distributors for Ovation educate these doctors? How much and when will we see a dramatic increase in Ovation sales? The next few quarters biosurgery sales should be quite interesting.....

      • 1 Reply to tensgut
      • I sure as shoot hope Osiris is being VERY aggressive and contacting all the hospitals and doctors that used INFUSE to make them aware of the products available from Osiris. I hope they aren't waiting for opportunity to come knocking but instead are out there knocking on doors themselves. This could be extremely fortuitous were Osiris to be extremely aggressive.

    • On the other side, Medtronic could be a goog candidate for partnering with Ovation, because BMP2`s sales continue to decrease, further could be faced to compensation following suing.

      Sentiment: Strong Buy

 
OSIR
5.6387-0.2313(-3.94%)12:44 PMEDT